A study of 5,067 overweight and obese T2D patients failed to demonstrate an association between mild weight reduction and improved cardiac function
L-Glutathione Reduced (GSH), Oxidized Glutathione (GSSG), S-Acetyl-L-Glutathione, Chitosan,&n
79 However, the FDA revised its guidance in 2020, moving toward a risk-based approach in which the need for a cardiovascular outcome trial is determined based on the drugs characteristics, safety profile, and existing cardiovascular risk data
This increases native GLP-1 levels in your bloodstream
Less common: Tingling or numbness in extremities Lightheadedness shortly after administration Drowsiness, particularly with evening doses Shared Risks Both compounds carry the general cautions associated with GH/IGF-1 axis activation: Glucose metabolism: Elevated GH can transiently increase blood glucose and reduce insulin sensitivity, particularly with extended continuous use